🚀 VC round data is live in beta, check it out!
NUTEX Valuation Multiples
Discover revenue and EBITDA valuation multiples for NUTEX and similar public comparables like PMGC Holdings, Synergy CHC, 7FIT, Rain Forest International and more.
NUTEX Overview
About NUTEX
NUTEX Investments PLC operates as a drug manufacturer in Hungary. The company is engaged in production of products that focuses on health, vitality, and natural ingredients.
Founded
1996
HQ
Employees
0
Website
Financials (FY)
Market Cap
$6M
NUTEX Financials
NUTEX reported last fiscal year revenue of $1K and EBITDA of $2M.
In the same fiscal year, NUTEX generated $1K in gross profit, $2M in EBITDA, and $1M in net income.
NUTEX P&L
In the most recent fiscal year, NUTEX reported revenue of $1K and EBITDA of $2M.
NUTEX expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $1K | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1K | XXX | XXX | XXX |
| Gross Margin | — | XXX | 100% | XXX | XXX | XXX |
| EBITDA | — | XXX | $2M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 103607% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (21482%) | XXX | XXX | XXX |
| Net Profit | — | XXX | $1M | XXX | XXX | XXX |
| Net Margin | — | XXX | 94092% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
NUTEX Stock Performance
NUTEX has current market cap of $6M.
Market Cap Evolution
NUTEX's stock price is $0.05.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $6M | 0.0% | XXX | XXX | XXX | $0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialNUTEX Valuation Multiples
NUTEX trades at (4511.2x) EV/Revenue multiple, and (4.4x) EV/EBITDA.
NUTEX Financial Valuation Multiples
As of April 19, 2026, NUTEX has market cap of $6M.
Equity research analysts estimate NUTEX's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
NUTEX has a P/E ratio of 4.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $6M | XXX | $6M | XXX | XXX | XXX |
| EV (current) | ($7M) | XXX | ($7M) | XXX | XXX | XXX |
| EV/Revenue | — | XXX | (4511.2x) | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (4.4x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 21.0x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (4511.2x) | XXX | XXX | XXX |
| P/E | — | XXX | 4.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 46.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified NUTEX Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
NUTEX Margins & Growth Rates
NUTEX's revenue in the last fiscal year grew by 0%.
NUTEX Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 103607% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 162% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 21582% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 21582% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
NUTEX Public Comps
See public comps and valuation multiples for other Nutraceuticals & Cosmeceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| NUTEX | XXX | XXX | XXX | XXX | XXX | XXX |
| PMGC Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Synergy CHC | XXX | XXX | XXX | XXX | XXX | XXX |
| 7FIT | XXX | XXX | XXX | XXX | XXX | XXX |
| Rain Forest International | XXX | XXX | XXX | XXX | XXX | XXX |
| Stem Cells Spin | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NUTEX M&A Activity
NUTEX acquired XXX companies to date.
Last acquisition by NUTEX was on XXXXXXXX, XXXXX. NUTEX acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by NUTEX
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialNUTEX Investment Activity
NUTEX invested in XXX companies to date.
NUTEX made its latest investment on XXXXXXXX, XXXXX. NUTEX invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by NUTEX
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout NUTEX
| When was NUTEX founded? | NUTEX was founded in 1996. |
| Where is NUTEX headquartered? | NUTEX is headquartered in Hungary. |
| How many employees does NUTEX have? | As of today, NUTEX has over 0 employees. |
| Is NUTEX publicly listed? | Yes, NUTEX is a public company listed on Budapest Stock Exchange. |
| What is the stock symbol of NUTEX? | NUTEX trades under NUTEX ticker. |
| When did NUTEX go public? | NUTEX went public in 1996. |
| Who are competitors of NUTEX? | NUTEX main competitors are PMGC Holdings, Synergy CHC, 7FIT, Rain Forest International. |
| What is the current market cap of NUTEX? | NUTEX's current market cap is $6M. |
| What is the current revenue of NUTEX? | NUTEX's last fiscal year revenue is $1K. |
| What is the current EV/Revenue multiple of NUTEX? | Current revenue multiple of NUTEX is (4511.2x). |
| Is NUTEX profitable? | No, NUTEX is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.